Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention

AIM: To evaluate the safety of four different dosages of alpha lipoic acid (400, 600, 800, and 1200 mg) as food supplement on adverse events related to alpha lipoic acid consumption and efficacy on glycemic status and lipid profile in subjects with euglycemia or dysglycemia. METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Derosa, Giuseppe, D’Angelo, Angela, Preti, Paola, Maffioli, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721112/
https://www.ncbi.nlm.nih.gov/pubmed/33299302
http://dx.doi.org/10.2147/DDDT.S280802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721112/
https://www.ncbi.nlm.nih.gov/pubmed/33299302
http://dx.doi.org/10.2147/DDDT.S280802

Ejemplares similares